Befejeződött1. fázis
A Phase I study to evaluate the pharmacokinetics, safety, and tolerability of multiple oral doses of obefazimod in patients with mild and moderate hepatic impairment, compared to matched control groups.
Key facts
- Where
- Kiel, NémetországSee the site
- Phase
- 1. fázis
Where in Németország
- CRS Clinical Research Services Management GmbHKiel, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Abivax
- Trial code
- EU 2023-505299-31-00
- Record updated
- 2024. április 30.